Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- AGATE-1Independent statistical analysis of A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and…
- Ageing and Health. Spanish Longitudinal Study: Complete Statistical AnalysisIndependent statistical analysis of Ageing and Health. Spanish Longitudinal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03343886).
- Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01530880).
- AGN-199201 for the Treatment of Erythema With Rosacea: Complete Statistical AnalysisIndependent statistical analysis of AGN-199201 for the Treatment of Erythema With Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01735201).
- AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02161146).
- AGREEIndependent statistical analysis of MPC-004 for the Treatment of an Acute Gout Flare: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506883).
- AHAvsSIMIndependent statistical analysis of A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT): primary endpoint results, effect estimate with confidence interval, sample-size…
- AIDAIndependent statistical analysis of Adjusting Insulin Delivery to Activity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02299479).
- AiME – 13Independent statistical analysis of A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance…
- Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01592760).
- Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath: Complete Statistical AnalysisIndependent statistical analysis of Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness…
- AIVARIXIndependent statistical analysis of Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ALCIndependent statistical analysis of Acetyl-L-Carnitine in the Treatment of Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00592488).
- Alcohol and Breast Cancer (ABC) Trial: Complete Statistical AnalysisIndependent statistical analysis of Alcohol and Breast Cancer (ABC) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05423730).
- Alemtuzumab + Rituximab Consolidation in CLL: Complete Statistical AnalysisIndependent statistical analysis of Alemtuzumab + Rituximab Consolidation in CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00771602).
- Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361711).
- ALFSG-MBTIndependent statistical analysis of 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer: Complete Statistical AnalysisIndependent statistical analysis of Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus: Complete Statistical AnalysisIndependent statistical analysis of Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults: Complete Statistical AnalysisIndependent statistical analysis of ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Alkali Therapy in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Alkali Therapy in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01452412).
- Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ALLIndependent statistical analysis of Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- All in Dads! Healthy Marriage and Responsible Fatherhood Program Evaluation: Complete Statistical AnalysisIndependent statistical analysis of All in Dads! Healthy Marriage and Responsible Fatherhood Program Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05194020).
- ALLAYIndependent statistical analysis of Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension: primary endpoint results, effect estimate with confidence…
- ALLAY-LID-IIndependent statistical analysis of Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ALLEGRO-2b/3Independent statistical analysis of PF-06651600 for the Treatment of Alopecia Areata: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03732807).
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs: Complete Statistical AnalysisIndependent statistical analysis of Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs: primary endpoint results, effect estimate with confidence interval, sample-size…
- Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3): Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides: Complete Statistical AnalysisIndependent statistical analysis of Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ALTA-3Independent statistical analysis of A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Altering Activation Patterns Post-stroke: Complete Statistical AnalysisIndependent statistical analysis of Altering Activation Patterns Post-stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02418949).
- ALTISSIMOIndependent statistical analysis of A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AltoidaMLIndependent statistical analysis of Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AmatuximabIndependent statistical analysis of An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AMAZEIndependent statistical analysis of Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06109428).
- AMEERA-3Independent statistical analysis of Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate…
- AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Aminotransferase Trends During Prolonged Acetaminophen Dosing: Complete Statistical AnalysisIndependent statistical analysis of Aminotransferase Trends During Prolonged Acetaminophen Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00743093).
- Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04790279).
- Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration: Complete Statistical AnalysisIndependent statistical analysis of Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AMPACT1Independent statistical analysis of AM-101 in the Treatment of Post-Acute Tinnitus 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01934010).
- Amplatzer Amulet China Post Market Study (PMS): Complete Statistical AnalysisIndependent statistical analysis of Amplatzer Amulet China Post Market Study (PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06189365).
- AMPLIFY-201Independent statistical analysis of A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…